Psilocybin is under clinical development by Filament Health and currently in Phase I for Substance (Drug) Abuse.
Psilocybin is under clinical development by Filament Health and currently in Phase I for Major Depressive Disorder.
ARFID is a newly recognised eating disorder, which became an official diagnosis for adults and children in 2013. For 12-year-old Alex*, the diagnosis came as a relief after years bouncing around the ...
A former glamour model mum from Devon is crowdfunding for help to conquer her debilitating phobia of vomit that she fears ...
Talk therapy and/or antidepressants can help address control issues, anxiety, depression, and other feelings that may underline hoarding tendencies, and make it easier for him to confront his disorder ...